{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T04:53:09Z","timestamp":1786683189516,"version":"build-2736575974"},"reference-count":20,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmedsci.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.amjms.2020.05.048","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T11:09:30Z","timestamp":1591182570000},"page":"724-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Report of a Family Pedigree"],"prefix":"10.1016","volume":"360","author":[{"given":"Grace","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Kimonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3118-1073","authenticated-orcid":false,"given":"Wei Ling","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.amjms.2020.05.048_bib0001","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1073\/pnas.051633798","article-title":"Inherited susceptibility to uterine leiomyomas and renal cell cancer","volume":"98","author":"Launonen","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.amjms.2020.05.048_bib0002","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jaad.2017.01.023","article-title":"Hereditary leiomyomatosis and renal cell cancer syndrome: an update and review","volume":"77","author":"Patel","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.amjms.2020.05.048_bib0003","first-page":"832","article-title":"Hereditary leiomyomatosis and renal cell cancer without cutaneous manifestations in two Japanese siblings","volume":"25","author":"Noguchi","year":"2018","journal-title":"Int J Urol Off J Jpn Urol Assoc"},{"issue":"1","key":"10.1016\/j.amjms.2020.05.048_bib0004","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1086\/376435","article-title":"Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America","volume":"73","author":"Toro","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.amjms.2020.05.048_bib0005","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-218270","article-title":"Hereditary leiomyomatosis and renal cell cancer syndrome: a family affair","author":"Teh","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"8","key":"10.1016\/j.amjms.2020.05.048_bib0006","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/s41588-018-0170-4","article-title":"Krebs-cycle-deficient hereditary cancer syndromes are defined by defects in homologous-recombination DNA repair","volume":"50","author":"Sulkowski","year":"2018","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.amjms.2020.05.048_bib0007","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.amjms.2020.05.048_bib0008","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/archderm.141.2.199","article-title":"Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome","volume":"141","author":"Alam","year":"2005","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.amjms.2020.05.048_bib0009","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1159\/000071802","article-title":"Familial leiomyomatosis: a review and discussion of pathogenesis","volume":"207","author":"Garman","year":"2003","journal-title":"Dermatol Basel Switz"},{"issue":"3","key":"10.1016\/j.amjms.2020.05.048_bib0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/1346-8138.13955","article-title":"Hereditary leiomyomatosis and renal cell cancer syndrome: a novel mutation in the FH gene","volume":"45","author":"Tsagoudis","year":"2018","journal-title":"J Dermatol"},{"issue":"8","key":"10.1016\/j.amjms.2020.05.048_bib0011","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1111\/1346-8138.14855","article-title":"Hereditary leiomyomatosis and renal cell cancer syndrome in which skin biopsy enabled diagnosis","volume":"46","author":"Matsuda","year":"2019","journal-title":"J Dermatol"},{"issue":"6","key":"10.1016\/j.amjms.2020.05.048_bib0012","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/jmg.2005.036400","article-title":"Increased risk of cancer in patients with fumarate hydratase germline mutation","volume":"43","author":"Lehtonen","year":"2006","journal-title":"J Med Genet"},{"issue":"1","key":"10.1016\/j.amjms.2020.05.048_bib0013","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.sult.2016.10.002","article-title":"Hereditary renal tumor syndromes: update on diagnosis and management","volume":"38","author":"Gaur","year":"2017","journal-title":"Semin Ultrasound CT MR"},{"issue":"7","key":"10.1016\/j.amjms.2020.05.048_bib0014","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/PAS.0000000000000626","article-title":"Immunohistochemistry for 2-Succinocysteine (2SC) and Fumarate Hydratase (FH) in cutaneous leiomyomas may aid in identification of patients with HLRCC (Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome)","volume":"40","author":"Buelow","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.amjms.2020.05.048_bib0015","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/path.2932","article-title":"Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status","volume":"225","author":"Bardella","year":"2011","journal-title":"J Pathol"},{"issue":"12","key":"10.1016\/j.amjms.2020.05.048_bib0016","first-page":"37","article-title":"Reed's syndrome: a Case of multiple cutaneous and uterine leiomyomas","volume":"4","author":"Emer","year":"2011","journal-title":"J Clin Aesthetic Dermatol"},{"issue":"12","key":"10.1016\/j.amjms.2020.05.048_bib0017","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1007\/s00345-018-2288-5","article-title":"Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management","volume":"36","author":"Maher","year":"2018","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.amjms.2020.05.048_bib0018","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10689-014-9735-2","article-title":"Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment","volume":"13","author":"Menko","year":"2014","journal-title":"Fam Cancer"},{"key":"10.1016\/j.amjms.2020.05.048_bib0019","doi-asserted-by":"crossref","unstructured":"Forde C, Lim DHK, Alwan Y, et al. Hereditary leiomyomatosis and renal cell cancer: clinical, molecular, and screening features in a cohort of 185 affected individuals [e-pub ahead of print]. Eur Urol Oncol. https:\/\/doi.org\/10.1016\/j.euo.2019.11.002. Accessed June 30, 2020.","DOI":"10.1016\/j.euo.2019.11.002"},{"issue":"1","key":"10.1016\/j.amjms.2020.05.048_bib0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12894-019-0484-2","article-title":"Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures","volume":"19","author":"Park","year":"2019","journal-title":"BMC Urol"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962920302421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962920302421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T18:37:54Z","timestamp":1757702274000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962920302421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S0002962920302421"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2020.05.048","relation":{},"ISSN":["0002-9629"],"issn-type":[{"value":"0002-9629","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): Report of a Family Pedigree","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2020.05.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}